Ludwig Kappos - Concepedia

Author

Ludwig Kappos

Also Known As

A Gallo, Anneke van der Walt, Antonio Gallo, B Casanova i Estruch, C Gasperini, Claudio Gasperini, Davorka Tomic, Ernst-Wilhelm Radü, F Barkhof, Franz Fazekas

1.3K

Publications

100.8K

Citations

137

H-Index

274

Concepts

All Affiliations

University Hospital of Basel University of Basel Heinrich Heine University Düsseldorf University of California, San Francisco Novartis (Switzerland)

About

Ludwig Kappos is an author at University Hospital of Basel specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	59	153	30.9K
2	Health Sciences	19	29	12.2K
3	Engineering	5	5	197
4	Arts	1	1	55
5	Education	1	1	34

Ludwig Kappos

511

Publications

74.5K

Citations

125

H-Index

Page 1

	Year	Citations
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria Chris H. Polman, Stephen C. Reingold, Brenda Banwell, Annals of Neurology Mcdonald CriteriaNeurological DisorderMedicineNeuroepidemiologyDiagnostic Criterion	2011	9.7K
Defining the clinical course of multiple sclerosis Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen, Neurology Neuroimaging BiomarkersSclerodermaNeurological DiseaseDisease ProgressionMedicine	2014	3K
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis Ludwig Kappos, Ernst‐Wilhelm Radue, Paul O’Connor, New England Journal of Medicine	2010	2.6K
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis Jeffrey A. Cohen, Frederik Barkhof, Hans‐Peter Hartung, New England Journal of Medicine	2010	2.2K
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni, New England Journal of Medicine	2016	1.9K
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos, New England Journal of Medicine	2016	1.8K
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis Ralf Gold, Ludwig Kappos, Douglas L. Arnold, New England Journal of Medicine	2012	1.7K
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis Giulio Disanto, Christian Barro, Pascal Benkert, Annals of Neurology	2017	1.1K
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis Ludwig Kappos, Jack P. Antel, Giancarlo Comi, New England Journal of Medicine	2006	1.1K
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis Paul O’Connor, Jerry S. Wolinsky, Christian Confavreux, New England Journal of Medicine	2011	965

Page 1